thioridazine has been researched along with salinomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Bhatia, M; Brown, ED; Collins, TJ; Fiebig-Comyn, A; Fischer-Russell, D; Foley, R; Giacomelli, AO; Graham, M; Hassell, JA; Laronde, S; Leber, B; Lee, JB; Lee, JH; Levadoux-Martin, M; Malig, M; McNicol, JD; Risueño, RM; Russell, J; Sachlos, E; Shapovalova, Z; Trus, MR; Xenocostas, A | 1 |
2 other study(ies) available for thioridazine and salinomycin
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.
Topics: Animals; Antineoplastic Agents; Cytarabine; Dopamine Antagonists; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Mefloquine; Mice; Neoplastic Stem Cells; Pluripotent Stem Cells; Pyrans; Thioridazine | 2012 |